pyrroles has been researched along with Insulinoma in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (45.45) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Alonso-Miguel, D; Clarés Moral, I; García-San José, P; González Sanz, S; Pérez-Alenza, MD | 1 |
| Chen, J; Cong, L; Cui, Y; Han, J; Luan, Y; Sha, D; Shen, R; Wang, C; Wang, W; Zhang, Z | 1 |
| Berruti, A; Pia, A; Terzolo, M | 1 |
| de Herder, WW; Feelders, RA; Kwekkeboom, D; van Schaik, E | 1 |
| Caviezel, C; Christofori, G; García-Echeverría, C; Hofmann, F; Pisarsky, L; Strittmatter, K; Zumsteg, A | 1 |
| Berezin, V; Billestrup, N; Bock, E; Heding, P; Li, S; Mandrup-Poulsen, T; Petersen, LG; Saldeen, J; Størling, J | 1 |
| Edwards, G; Weston, AH | 2 |
| Ayton, BA; Dunne, MJ; Harding, EA; Jaggar, JH | 1 |
| Dan, K; Hirose, H; Maruyama, H; Nakamura, K; Saruta, T; Seto, Y | 1 |
| Fuhlendorff, J; Gromada, J; Madsen, P; Springborg, J; Varming, AR | 1 |
1 review(s) available for pyrroles and Insulinoma
| Article | Year |
|---|---|
New therapeutic options for metastatic malignant insulinomas.
Topics: Antineoplastic Agents; Everolimus; Humans; Indoles; Insulinoma; Liver Neoplasms; Pancreatic Neoplasms; Pyrroles; Radiopharmaceuticals; Receptors, Somatostatin; Sirolimus; Somatostatin; Sunitinib | 2011 |
10 other study(ies) available for pyrroles and Insulinoma
| Article | Year |
|---|---|
Evaluation of palliative therapy, alone or in combination with toceranib phosphate, in dogs diagnosed with metastatic or recurrent beta-cell neoplasia.
Topics: Animals; Antineoplastic Agents; Dog Diseases; Dogs; Hospitals, Animal; Hospitals, Teaching; Indoles; Insulinoma; Palliative Care; Pancreatic Neoplasms; Pyrroles; Retrospective Studies | 2021 |
Therapeutic effect of sunitinib malate and its influence on blood glucose concentrations in a patient with metastatic insulinoma.
Topics: Aged; Antineoplastic Agents; Blood Glucose; Fluorodeoxyglucose F18; Humans; Indoles; Insulinoma; Liver Neoplasms; Male; Positron-Emission Tomography; Pyrroles; Sunitinib; Tomography, Emission-Computed | 2013 |
Advances in pancreatic neuroendocrine tumor treatment.
Topics: Animals; Antineoplastic Agents; Diabetes Mellitus, Type 1; Glucagonoma; Humans; Indoles; Insulinoma; Mice; Neuroendocrine Tumors; Pancreatic Neoplasms; Pyrroles; Receptors, Platelet-Derived Growth Factor; Sunitinib | 2011 |
Repression of malignant tumor progression upon pharmacologic IGF1R blockade in a mouse model of insulinoma.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Immunoblotting; In Situ Nick-End Labeling; Insulinoma; Mice; Mice, Transgenic; Oligonucleotide Array Sequence Analysis; Pancreatic Neoplasms; Phosphorylation; Pyrimidines; Pyrroles; Receptor, IGF Type 1; Reverse Transcriptase Polymerase Chain Reaction; Tumor Burden | 2012 |
IL-1beta-induced pro-apoptotic signalling is facilitated by NCAM/FGF receptor signalling and inhibited by the C3d ligand in the INS-1E rat beta cell line.
Topics: Animals; Cell Line; Complement C3d; Hippocampus; Insulin-Secreting Cells; Insulinoma; Interleukin-1; Neural Cell Adhesion Molecules; Neurons; Pancreatic Neoplasms; Phosphorylation; Pyrroles; Rats; Rats, Wistar; Receptor, Fibroblast Growth Factor, Type 1; Receptors, Fibroblast Growth Factor; Recombinant Proteins; Signal Transduction; Tumor Cells, Cultured | 2006 |
KATP--fact or artefact? New thoughts on the mode of action of the potassium channel openers.
Topics: Animals; Benzopyrans; Cromakalim; Electrophysiology; Guanidines; Insulinoma; Ion Channel Gating; Muscle, Smooth, Vascular; Pancreatic Neoplasms; Phosphorylation; Picolines; Potassium Channels; Pyrans; Pyrroles; Rats; Tumor Cells, Cultured; Vasodilator Agents | 1994 |
Activation of potassium channels by diazoxide and cromakalim in insulin-secreting cells is dependent upon internal ADP and channel run-down.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Benzopyrans; Cell Line; Cromakalim; Diazoxide; Insulin; Insulin Secretion; Insulinoma; Islets of Langerhans; Kinetics; Pancreatic Neoplasms; Potassium Channels; Pyrroles; Tumor Cells, Cultured | 1993 |
Induction of a glibenclamide-sensitive K-current by modification of a delayed rectifier channel in rat portal vein in insulinoma cells.
Topics: Animals; Benzopyrans; Cromakalim; Glyburide; Insulinoma; Neurotoxins; Phosphorylation; Portal Vein; Potassium Channels; Pyrroles; Rats; Scorpion Venoms; Tumor Cells, Cultured | 1993 |
Effects of alpha 2-adrenergic agonism, imidazolines, and G-protein on insulin secretion in beta cells.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Clonidine; Cricetinae; Glucose; GTP-Binding Proteins; Humans; Imidazoles; Indoles; Insulin; Insulin Secretion; Insulinoma; Islets of Langerhans; Kinetics; Molecular Structure; Oxymetazoline; Pancreatic Neoplasms; Pertussis Toxin; Phentolamine; Pyrroles; Quinolizines; Receptors, Adrenergic, alpha-2; Tumor Cells, Cultured; Virulence Factors, Bordetella | 1997 |
Increase in [Ca2+]i and subsequent insulin release from beta TC3-cells with the L-type Ca(2+)-channel activator, FPL 64176.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Antigens, Polyomavirus Transforming; Calcium; Calcium Channel Agonists; Calcium Channels; Calcium Channels, L-Type; Dose-Response Relationship, Drug; Glyburide; Insulin; Insulin Secretion; Insulinoma; Kinetics; Mice; Mice, Transgenic; Pancreatic Neoplasms; Promoter Regions, Genetic; Pyrroles; Simian virus 40; Tumor Cells, Cultured | 1997 |